Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. EMIS Group plc
  6. News
  7. Summary
    EMIS   GB00B61D1Y04

EMIS GROUP PLC

(EMIS)
  Report
Delayed Quote. Delayed London Stock Exchange - 07/23 11:35:18 am
1240 GBX   +2.48%
07/13FTSE 100 Closed Slightly Lower, With UK Banks Reversing Early Optimism
DJ
07/13Sterling Investors Torn Between Optimism And Virus Concerns
DJ
07/13London Shares to Open Flat After Mixed Asia Data
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EMIS : Trading Update and Notice of Final Results

01/23/2020 | 02:44am EDT
Trading Update and Notice of Final Results

Released : 23/01/20 07:00

RNS Number : 6522A
EMIS Group PLC
23 January 2020

23 January 2020

EMIS Group plc

('EMIS Group' or 'the Group')

Trading update

Notice of final results

EMIS Group plc (AIM: EMIS.L), the UK leader in connected healthcare software and systems, today announces a trading update for the year ended 31 December 2019.

Overview

Trading for the year was in line with the Board's expectations, with growth in both revenue and adjusted operating profit maintained at similar levels to the half year.

Divisional review

In EMIS Health, the Group's leading NHS market shares were maintained, and the GP IT Futures English GP Framework renewal process was successfully concluded, as previously announced on 21 October 2019.

EMIS Enterprise continued to make good progress, including in the Patient business, with the controlled roll-out of new functionality within its Patient Access app completing the first phase of the connected healthcare marketplace.

As previously indicated, the Group continues to invest in the development of its next generation EMIS-X software platform. The Group also completed its reorganisation in the second half of the year, while undertaking further productivity and process improvements.

Financial position

The Group has a strong balance sheet with net cash of £31.1m as at 31 December 2019 (31 December 2018: £15.6m).

Notice of final results

The Group intends to announce its results for the year ended 31 December 2019 on 18 March 2020.

For further information, contact:

EMIS Group plc Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000

Oliver Hardy/Simon Willis/James Black

MHP Communications Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo

Information for investors, including analyst consensus forecasts, can be found on the Group's website at www.emisgroupplc.com/investors.

Notes to Editors

EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and UK healthcare blockchain.

EMIS Group's brands include:

EMIS Health, supplying innovative and essential technology to 10,000 healthcare organisations, in the number one or number two market positions in each of its major markets;

Patient, the UK's leading independent provider of patient-centric medical and well-being information and related transactional services;

Egton, providing specialist ICT infrastructure, hardware and engineering services, and non-clinical software into health and social care; and

Dovetail Lab, a health technology company developing blockchain software to facilitate the integration of healthcare data.

LEI: 213800K474ZZK76NX913


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TSTBIGDBRGDDGGD

Disclaimer

EMIS Group plc published this content on 23 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2020 07:43:04 UTC


© Publicnow 2020
All news about EMIS GROUP PLC
07/13FTSE 100 Closed Slightly Lower, With UK Banks Reversing Early Optimism
DJ
07/13Sterling Investors Torn Between Optimism And Virus Concerns
DJ
07/13London Shares to Open Flat After Mixed Asia Data
DJ
07/13U.K. Bank Shares Rise After Removal of Dividend Curbs
DJ
07/13EMIS : Says H1 Results to Top Pre-COVID-19 Levels
MT
07/13EMIS Group plc Reports Trading Results for the Six Months Ended June 30, 2021
CI
05/06EMIS : Trading In Line With Expectations; Staff To Slowly Return To Workplace
MT
04/15EMIS GROUP PLC : Ex-dividend day for final dividend
FA
03/21BACK ON THE GROWTH TRACK : a research report by Edison
PU
03/18EMIS : Lifts Dividend As 2020 Profit Grows
MT
More news
Financials
Sales 2021 164 M 226 M 226 M
Net income 2021 30,9 M 42,5 M 42,5 M
Net cash 2021 53,0 M 72,8 M 72,8 M
P/E ratio 2021 26,6x
Yield 2021 2,70%
Capitalization 781 M 1 074 M 1 073 M
EV / Sales 2021 4,43x
EV / Sales 2022 4,15x
Nbr of Employees 1 591
Free-Float 94,3%
Chart EMIS GROUP PLC
Duration : Period :
EMIS Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 1 240,00 GBX
Average target price 1 268,25 GBX
Spread / Average Target 2,28%
EPS Revisions
Managers and Directors
Andrew John Thorburn Chief Executive Officer & Executive Director
Peter John Southby Chief Financial Officer & Executive Director
Patrick Jean-Marie de Smedt Chairman
Shaun O’Hanlon Chief Medical Officer
Pete Malcolm Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
EMIS GROUP PLC14.60%1 007
VEEVA SYSTEMS INC.20.50%47 778
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-38.69%30 909
OMNICELL, INC.26.73%6 479
CLOVER HEALTH INVESTMENTS, CORP.-48.60%5 293
PRO MEDICUS LIMITED70.78%4 505